Megan Ricord, BS; Frank M. Andrews, DVM, MS, DACVIM (LA); Francisco J. Morales Yn˜ iguez, DVM; Michael L. Keowen, BS; Frank Garza, Jr, MS; Linda Paul, DVM; Ann Chapman, DVM, MS, DACVIM (LA); and Heidi Banse, DVM, PhD, DACVIM (LA)

Omeprazole ameliorates phenylbutazone-induced gastric glandular ulceration, but may increase the rate of intestinal complications. Risk of complications should be considered when co-administering omeprazole and phenylbutazone in horses.

Post Type

  • Article
  • Convention Proceedings Article

Topic

  • Gastric Disease
  • Gastric Ulcers
  • Omeprazole
  • Phenylbutazone

Publish Date

December 1, 2020

Related Articles

December 15, 2025

Outcome of horses with chronic gastric dilatation and delayed gastric emptying treated with oral metoclopramide

This content is an exclusive benefit for AAEP members. If you’re a…

December 6, 2025

Characterization of Vonoprazan, A Novel Treatment for Gastric Ulcers in Horses

This content is an exclusive benefit for AAEP members. If you’re a…

December 6, 2025

Phenylbutazone Does Not Have an Effect on the in Vitro Production of Equine Embryos

This content is an exclusive benefit for AAEP members. If you’re a…